{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T17:53:51Z","timestamp":1773251631899,"version":"3.50.1"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","license":[{"start":{"date-parts":[[2024,7,26]],"date-time":"2024-07-26T00:00:00Z","timestamp":1721952000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["J Low Genit Tract Dis"],"published-print":{"date-parts":[[2024,10]]},"abstract":"<jats:sec>\n            <jats:title>Objectives<\/jats:title>\n            <jats:p>This study was designed to evaluate the performance of a host gene methylation marker panel (ASTN1, DLX1, ITGA4, RXFP3, SOX17, and ZNF671) in the triage of human papillomavirus (HPV)-positive women, its possible impact in a cervical cancer screening program, and the possible influence of the variation of the rate of HPV16\/18 in its performance.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Materials and Methods<\/jats:title>\n            <jats:p>Cohort study in which consecutive women referred for colposcopy in an organized cervical cancer screening program had repeated HPV testing, colposcopy, and biopsies. The women that remained HPV positive at the time of colposcopy were tested with the panel of DNA methylation markers. The performance of the test was evaluated and compared to standard practice.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>The study test had a sensitivity and specificity for cervical intraepithelial neoplasia (CIN) 2+ of 60.8% (49.1\u201371.6%) and 88.4% (83.2\u201392.5%), respectively. For CIN3+, it was of 78.0% (64.0\u201388.5%) and 86.0% (80.8\u201390.2%), respectively. The rate and level of methylation positively correlated with the severity of disease. The use of methylation reduces the referral for colposcopy to 25.5%, while detecting 78.0% of the CIN3+ cases. Referral of all HPV16\/18-positive cases and triage of the other high-risk HPV-positive cases with methylation, detects 90.0% of the cases of CIN3+, while reducing the number of referrals to 43.2%. The variation in the rate of HPV16\/18 does not relevantly affect the performance of the methylation panel.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>The studied methylation panel has a high sensitivity and specificity for CIN3+ and reduces the rate of referrals for colposcopy, without relevant variation according to the rate of HPV16\/18.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/lgt.0000000000000830","type":"journal-article","created":{"date-parts":[[2024,7,26]],"date-time":"2024-07-26T14:29:29Z","timestamp":1722004169000},"page":"326-331","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":7,"title":["Evaluation of Host Gene Methylation as a Triage Test for HPV-Positive Women\u2014A Cohort Study"],"prefix":"10.1097","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5335-6770","authenticated-orcid":false,"given":"Pedro","family":"Vieira-Baptista","sequence":"first","affiliation":[]},{"given":"Mariana","family":"Costa","sequence":"additional","affiliation":[{"name":"Unilabs Portugal, Laborat\u00f3rio de Biologia Molecular, Porto, Portugal"}]},{"given":"Juliane","family":"Hippe","sequence":"additional","affiliation":[{"name":"Oncgnostics GmbH, Jena, Germany"}]},{"given":"Carlos","family":"Sousa","sequence":"additional","affiliation":[{"name":"Unilabs Portugal, Laborat\u00f3rio de Biologia Molecular, Porto, Portugal"}]},{"given":"Martina","family":"Schmitz","sequence":"additional","affiliation":[{"name":"Oncgnostics GmbH, Jena, Germany"}]},{"given":"Ana-Rita","family":"Silva","sequence":"additional","affiliation":[{"name":"Unilabs Portugal, Laborat\u00f3rio de Biologia Molecular, Porto, Portugal"}]},{"given":"Alfred","family":"Hansel","sequence":"additional","affiliation":[{"name":"Oncgnostics GmbH, Jena, Germany"}]},{"given":"Mario","family":"Preti","sequence":"additional","affiliation":[{"name":"Department of Surgical Sciences University of Torino, Italy"}]}],"member":"276","published-online":{"date-parts":[[2024,7,26]]},"reference":[{"key":"bib1-20250524","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/LGT.0000000000000614","article-title":"The ASCCP Cervical Cancer Screening Task Force Endorsement and Opinion on the American Cancer Society Updated Cervical Cancer Screening Guidelines","volume":"25","year":"2021","journal-title":"J Low Genit Tract Dis"},{"key":"bib2-20250524","doi-asserted-by":"crossref","first-page":"107395","DOI":"10.1016\/j.ypmed.2022.107395","article-title":"A synthesis of evidence for cancer-specific screening interventions: a preventive medicine golden jubilee review","volume":"167","year":"2023","journal-title":"Prev Med"},{"key":"bib3-20250524","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.pvr.2015.06.006","article-title":"European guidelines for quality assurance in cervical cancer screening. Summary of the supplements on HPV screening and vaccination","volume":"1","year":"2015","journal-title":"Papillomavirus Res"},{"key":"bib4-20250524","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/LGT.0000000000000103","article-title":"Use of primary high-risk human papillomavirus testing for cervical cancer screening: interim clinical guidance","volume":"19","year":"2015","journal-title":"J Low Genit Tract Dis"},{"key":"bib5-20250524","first-page":"Cd012847","article-title":"Obstetric outcomes after conservative treatment for cervical intraepithelial lesions and early invasive disease","volume":"11","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"bib6-20250524","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1158\/1055-9965.EPI-17-0534","article-title":"Defining optimal triage strategies for hrHPV screen-positive women\u2014an evaluation of HPV 16\/18 genotyping, cytology, and p16\/Ki-67 cytoimmunochemistry","volume":"26","year":"2017","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"bib7-20250524","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1038\/s41416-020-0787-9","article-title":"Triage of HPV-positive women in Norway using cytology, HPV16\/18 genotyping and HPV persistence","volume":"122","year":"2020","journal-title":"Br J Cancer"},{"key":"bib8-20250524","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/s13148-023-01517-6","article-title":"Identification of a methylation panel as an alternative triage to detect CIN3+ in hrHPV-positive self-samples from the population-based cervical cancer screening programme","volume":"15","year":"2023","journal-title":"Clin Epigenetics"},{"key":"bib9-20250524","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1002\/cncy.21596","article-title":"HPV DNA testing with cytology triage in cervical cancer screening: Influence of revealing HPV infection status","volume":"123","year":"2015","journal-title":"Cancer Cytopathol"},{"key":"bib10-20250524","first-page":"115","article-title":"Beyond P16\/Ki67 dual-stain cytology: exploring alternative biomarkers for diagnosing cervical cancer and its precursors","volume":"131","year":"2023","journal-title":"BJOG"},{"key":"bib11-20250524","doi-asserted-by":"crossref","first-page":"6479","DOI":"10.3390\/ijms24076479","article-title":"The role of methylation of host and\/or human papillomavirus (HPV) DNA in management of cervical intraepithelial neoplasia grade 2 (CIN2) lesions","volume":"24","year":"2023","journal-title":"Int J Mol Sci"},{"key":"bib12-20250524","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1186\/s12885-018-5125-8","article-title":"Performance of a DNA methylation marker panel using liquid-based cervical scrapes to detect cervical cancer and its precancerous stages","volume":"18","year":"2018","journal-title":"BMC Cancer"},{"key":"bib13-20250524","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.ebiom.2019.10.053","article-title":"The use of human papillomavirus DNA methylation in cervical intraepithelial neoplasia: a systematic review and meta-analysis","volume":"50","year":"2019","journal-title":"EBioMedicine"},{"key":"bib14-20250524","doi-asserted-by":"crossref","first-page":"e28414","DOI":"10.1002\/jmv.28414","article-title":"Impact of high-risk human papillomavirus genotyping in cervical disease in the northern region of Portugal: real-world data from regional cervical cancer screening program","volume":"95","year":"2023","journal-title":"J Med Virol"},{"key":"bib15-20250524","doi-asserted-by":"crossref","first-page":"177","DOI":"10.4103\/2452-2473.357348","article-title":"User's guide to sample size estimation in diagnostic accuracy studies","volume":"22","year":"2022","journal-title":"Turk J Emerg Med"},{"key":"bib16-20250524","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/s13148-017-0419-2","article-title":"Performance of a methylation specific real-time PCR assay as a triage test for HPV-positive women","volume":"9","year":"2017","journal-title":"Clin Epigenetics"},{"key":"bib17-20250524","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1097\/LGT.0000000000000564","article-title":"Impact of a high coverage vaccination rate on human papillomavirus infection prevalence in young women: a cross-sectional study","volume":"24","year":"2020","journal-title":"J Low Genit Tract Dis"},{"key":"bib18-20250524","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1186\/s13148-020-00963-w","article-title":"Triage of hrHPV-positive women: comparison of two commercial methylation-specific PCR assays","volume":"12","year":"2020","journal-title":"Clin Epigenetics"},{"key":"bib19-20250524","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1097\/LGT.0000000000000452","article-title":"Immediate loop electrode excisional procedure for high-grade cervical cytology: one size fits all?","volume":"23","year":"2019","journal-title":"J Low Genit Tract Dis"},{"key":"bib20-20250524","first-page":"113","article-title":"Provider- and facility-level variation in precancerous cervical biopsy diagnoses","volume":"27","year":"2023","journal-title":"J Low Genit Tract Dis"},{"key":"bib21-20250524","doi-asserted-by":"crossref","first-page":"656.e1","DOI":"10.1016\/j.ajog.2023.08.008","article-title":"Clinical course of cervical intraepithelial neoplasia grade 2: a population based study","volume":"229","year":"2023","journal-title":"Am J Obstet Gynecol"},{"key":"bib22-20250524","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.jasc.2020.07.133","article-title":"Are CIN3 risk or CIN3+ risk measures reliable surrogates for invasive cervical cancer risk?","volume":"9","year":"2020","journal-title":"J Am Soc Cytopathol"},{"key":"bib23-20250524","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1002\/ijc.28138","article-title":"CADM1 and MAL promoter methylation levels in hrHPV-positive cervical scrapes increase proportional to degree and duration of underlying cervical disease","volume":"133","year":"2013","journal-title":"Int J Cancer"},{"key":"bib24-20250524","doi-asserted-by":"crossref","first-page":"c1040","DOI":"10.1136\/bmj.c1040","article-title":"HPV testing on self collected cervicovaginal lavage specimens as screening method for women who do not attend cervical screening: cohort study","volume":"340","year":"2010","journal-title":"BMJ"},{"key":"bib25-20250524","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/bjc.2016.200","article-title":"FAM19A4 methylation analysis in self-samples compared with cervical scrapes for detecting cervical (pre)cancer in HPV-positive women","volume":"115","year":"2016","journal-title":"Br J Cancer"},{"key":"bib26-20250524","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.2217\/epi-2022-0160","article-title":"A systematic review and meta-analysis of the diagnostic effectiveness of human papillomavirus methylation biomarkers for detection of cervical cancer","volume":"14","year":"2022","journal-title":"Epigenomics"},{"key":"bib27-20250524","doi-asserted-by":"crossref","first-page":"114219","DOI":"10.1016\/j.jviromet.2021.114219","article-title":"Performance of a six-methylation-marker assay on self-collected cervical samples - a feasibility study","volume":"295","year":"2021","journal-title":"J Virol Methods"},{"key":"bib28-20250524","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.3390\/diagnostics13142384","article-title":"The value of four-quadrant cervical biopsy in women with different colposcopic impressions","volume":"13","year":"2023","journal-title":"Diagnostics (Basel)"}],"container-title":["Journal of Lower Genital Tract Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/LGT.0000000000000830","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,24]],"date-time":"2025-05-24T20:00:51Z","timestamp":1748116851000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/LGT.0000000000000830"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,26]]},"references-count":28,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/lgt.0000000000000830","relation":{},"ISSN":["1526-0976"],"issn-type":[{"value":"1526-0976","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,26]]}}}